| Accession Number | 0001813798-26-000023 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 7, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Ofc, COO | Common Stock | โ | Oct 5, 2026 | Exercise/Conversion | 18,000 | $5.35 | $96,300.00 | 163,435 | Direct | โ | View Details | |
EVP, Chief Scientific Ofc, COO | Common Stock | โ | Oct 5, 2026 | Sale | 18,000 | $86.74 | $1,561,320.00 | 145,435 | Direct | โ | View Details | |
EVP, Chief Scientific Ofc, COO | Stock Option (right to buy) | Derivative | Oct 5, 2026 | Exercise/Conversion | 18,000 | $0.00 | $0.00 | 46,398 | Direct | โ | View Details |